Device Trial Radar · NCT00543270
Powerlink Bifurcated Stent Graft Long-Term Follow-up Study
Last checked: Nov 20, 2026Latest source record: Oct 5, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
258
Actual
Start
Oct 2005
Primary completion
Nov 2009
Study completion Nov 2009
Sponsor
- Lead sponsor
- EndologixNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 12, 2007
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Endologix Infrarenal Bifurcated Stent Graft Study
Conditions
- Abdominal Aortic Aneurysm
Interventions
Powerlink infrarenal bifurcated stent graft delivery systemDevice
Endovascular abdominal aortic aneurysm repair
Open SurgeryProcedure
Open surgical abdominal aortic aneurysm repair
Primary outcomes
What the sponsor says the trial is designed to measure.
- No of Subjects with Major adverse eventsTime frame: At 1 Year
- All Cause MortalityTime frame: At 1 Year
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Arizona Heart Institute
Phoenix, Arizona
Harbor-UCLA Medical Center
Torrance, California
University of Illinois School of Medicine
Peoria, Illinois
11 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.